Atlas Trials

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00720499 · COMPLETED

Trial details

NCT number
NCT00720499
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2008-07-01
Primary completion
2009-02-01
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.